Sign in

CIK 0001855175 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Contineum Therapeutics, Inc.

Sign in to watch
Ticker
CTNM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
271467257
Phone
(858) 333-5280
Business address
3565 GENERAL ATOMICS COURT, SUITE 200, SAN DIEGO, CA, 92121
  1. 4 Planned sale CEO and President sold 2,500 shares at $16.46 ($41,142)
  2. 4 Planned sale CEO and President sold 2,500 shares at $16.01 ($40,029)
  3. 4 Planned sale Chief Scientific Officer sold 1,040 shares at $16.00 ($16,640)
  4. 4 Planned sale CEO and President sold 2,500 shares at $16.00 ($40,000)
  5. 4 Planned sale Chief Scientific Officer sold 37,179 shares at an average $15.99 ($594,578)
  6. 4 Planned sale CMO & Head of Development sold 10,833 shares at $16.02 ($173,590)
  7. 4 Planned sale CEO and President sold 10,000 shares at $16.01 ($160,080)
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Planned sale Chief Scientific Officer sold 4,170 shares at $13.16 ($54,862)
  16. 4 Planned sale Chief Scientific Officer sold 4,170 shares at an average $13.12 ($54,694)
  17. 4 Planned sale Chief Scientific Officer sold 4,170 shares at $13.43 ($56,014)
  18. 4 Planned sale Chief Scientific Officer sold 4,170 shares at $15.01 ($62,585)
  19. 4 Planned sale CMO & Head of Development sold 3,611 shares at $15.02 ($54,220)
  20. 4 Planned sale CEO and President sold 7,100 shares at an average $16.02 ($113,728)

Page 1 of 4 · 78 filings